ReviewFrontiers in microbiology2026
Nanozyme-based biosensors for pathogenic microorganism detection: a mini-review.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanozyme technology has surfaced as a game-changing tool in the detection of pathogenic microorganisms, serving as an appealing substitute for traditional biosensing methods. This review first highlighted the unique catalytic mechanisms of nanozymes, including peroxidase-like, catalase-like, oxidase-like, and superoxide dismutase-like activities, which are fundamental to their usefulness. Second, we explored mainstream biosensing platforms, such as colorimetric/lateral flow assays, electrochemical sensors, fluorescent/dual-modal systems, and nanozyme-CRISPR synergistic approaches. Each of these systems benefited from the stability, tunability, and cost-effectiveness of nanozymes. Third, the applications of nanozyme-based biosensors in the diagnosis of clinical pathogens, the detection of foodborne bacteria, and the monitoring of environmental microorganisms were further analyzed. Finally, the future directions of nanozyme-based biosensors were discussed to advance their clinical and industrial translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.